Pharma Globenewswire

Somatotropin Deficiency Market Outlook Expands with Advancements in Hormone Therapies and Diagnostics

20 March 2026

The healthcare landscape continues to evolve as endocrine disorders gain increased clinical and commercial attention. Among these, Somatotropin Deficiency – commonly referred to as growth hormone deficiency – has emerged as a critical focus area due to its long-term impact on growth,

Uncategorised

Plaque Psoriasis Market Outlook 2026–2034 Driven by Innovation, Biologics, and Rising Disease Burden

20 March 2026

The Plaque Psoriasis market continues to evolve as one of the most significant segments within dermatology and immunology, driven by innovation, increasing disease awareness, and the introduction of targeted therapies. With a growing patient population and expanding treatment landscape, the market

Uncategorised

Venous Thromboembolism Market Expands Rapidly with Advancements in Diagnostics, Therapeutics, and Epidemiological Insights Driving Future Growth

20 March 2026

The Venous Thromboembolism (VTE) market is witnessing significant expansion, driven by rising incidence rates, advancements in diagnostic technologies, and the introduction of innovative therapeutics. Increasing awareness among healthcare professionals and patients, coupled with improved healthcare infrastructure, is further contributing to the growth

Uncategorised

Congestive Heart Failure Market Size (7MM) was ~USD 6,900 Million in 2023 and It is expected to grow by 2034, estimates DelveInsight

20 March 2026

DelveInsight’s “Congestive Heart Failure Market Insight, Epidemiology and Market Forecast – 2034” report delivers an in-depth understanding of Congestive Heart Failure, historical and forecasted epidemiology as well as the Congestive Heart Failure market trends in the United States, EU4 (Germany, France, Italy,

Uncategorised

Pigment Epithelial Detachment Market Expected to Experience Substantial Expansion Across 7MM, Propelled by Growing Elderly Demographics and Breakthrough Treatments | DelveInsight

20 March 2026

The pigment epithelial detachment (PED) market is set for remarkable expansion, underpinned by multiple contributing factors such as a rising geriatric population, breakthroughs in artificial intelligence-based diagnostics, strategic industry partnerships, and the emergence of next-generation treatment modalities. Leading companies operating in the

Uncategorised

Emerging Therapies Set to Propel the TRK Fusion Cancer Market Through 2032: DelveInsight Report

20 March 2026

DelveInsight has released a comprehensive new report, “TRK Fusion Cancer – Market Insights, Epidemiology, and Market Forecast-2032.” This publication offers an in-depth analysis of TRK Fusion Cancer, including historical and projected epidemiology, alongside detailed market trends across the seven major markets (7MM):

Uncategorised

DelveInsight’s Trichotillomania Market Analysis, Epidemiological Data, and Forecast Through 2032

20 March 2026

DelveInsight’s comprehensive report titled “Trichotillomania Market Insights, Epidemiology, and Market Forecast-2032” provides a thorough examination of the condition, including historical and projected epidemiological data alongside emerging market trends across the United States, EU5 nations (Germany, Spain, Italy, France, and the United Kingdom),

Uncategorised

Transverse Myelitis Market Insights Report 2034 | DelveInsight

20 March 2026

DelveInsight’s Transverse Myelitis Market Insights Report 2034 provides the current and forecast market analysis, individual leading Transverse Myelitis companies’ market shares, challenges, market drivers, barriers, trends, and key companies operating in the market. To read more about the latest highlights related to

Market Insights

Motor Neuron Disease Pipeline Insight 2026: Driving Hope Through Next-Generation Therapies

19 March 2026

Motor Neuron Disease is a progressive neurodegenerative disorder that primarily affects motor neurons, leading to muscle weakness, wasting, and, ultimately, respiratory failure. Amyotrophic lateral sclerosis (ALS) is the most prevalent form of Motor Neuron Disease. Current treatment options are largely limited to

Latest

Somatotropin Deficiency Market Outlook Expands with Advancements in Hormone Therapies and Diagnostics

Plaque Psoriasis Market Outlook 2026–2034 Driven by Innovation, Biologics, and Rising Disease Burden

Venous Thromboembolism Market Expands Rapidly with Advancements in Diagnostics, Therapeutics, and Epidemiological Insights Driving Future Growth

Congestive Heart Failure Market Size (7MM) was ~USD 6,900 Million in 2023 and It is expected to grow by 2034, estimates DelveInsight

Pigment Epithelial Detachment Market Expected to Experience Substantial Expansion Across 7MM, Propelled by Growing Elderly Demographics and Breakthrough Treatments | DelveInsight

Emerging Therapies Set to Propel the TRK Fusion Cancer Market Through 2032: DelveInsight Report

DelveInsight’s Trichotillomania Market Analysis, Epidemiological Data, and Forecast Through 2032

Transverse Myelitis Market Insights Report 2034 | DelveInsight

Motor Neuron Disease Pipeline Insight 2026: Driving Hope Through Next-Generation Therapies

Recent Posts

Banner

Newsletter

Authors